Altogether, these findings indicate that MMP14, a zinc (Zn2+)‐dependent endopeptidase, and NCOR2, a transcriptional corepressor, are additional promising candidate targets of the autoantibodies from our original study and may become accessible to circulating ligands in ovarian cancer. The gene discussed is NCOR2; the disease is ovarian carcinoma.